Schroder Investment Management Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-24,556
Closed -$3.77M 1649
2021
Q1
$3.77M Buy
+24,556
New +$3.33M ﹤0.01% 879
2019
Q4
Sell
-8,300
Closed -$817K 1369
2019
Q3
$817K Buy
+8,300
New +$824K ﹤0.01% 1006
2017
Q4
Sell
-4,963
Closed -$377K 1399
2017
Q3
$377K Sell
4,963
-2,059
-29% -$156K ﹤0.01% 1116
2017
Q2
$528K Buy
+7,022
New +$487K ﹤0.01% 1063

Other funds holding PRAH

Schroder Investment Management Group's PRAH Position: Q2 2021 in Review

Schroder Investment Management Group sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 24,556 shares — an estimated $3.77M sold.

Schroder Investment Management Group first reported a position in PRAH in Q2 2017 and held it in 4 quarters. The position peaked at $3.77M in Q1 2021. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • Schroder Investment Management Group reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Schroder Investment Management Group sold 24,556 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $3.77M.
  • Schroder Investment Management Group first reported a position in PRA Health Sciences, Inc. in Q2 2017 and held it in 4 quarters.
  • Schroder Investment Management Group's PRA Health Sciences, Inc. position peaked at $3.77M in Q1 2021.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Schroder Investment Management Group's 13F filing for Q2 2021, filed 13 Aug 2021.